The bioavailability problem Absorption comparison: Injection: 80-100% bioavailability (nearly all absorbed) Nasal spray: 30-70% bioavailability (varies by peptide) Oral: 0-5% bioavailability (most peptides destroyed) Why nasal lower than injection: Must penetrate nasal mucosa (barrier) Some drips down throat (swallowed = lost) Variable absorption efficiency Technique-dependent Individual variation high What this means: You need MORE peptide via nasal spray Typically 2-3x higher dose than injection Example: 1mg injection = 2-3mg nasal Increases cost significantly But still cheaper/easier than injection for some Conversion guidelines by peptide PT-141: Injection: 1.5-2mg typical dose Nasal equivalent: 3-5mg Conversion ratio: 2-3x Semax: Designed for nasal use (no conversion needed) Standard nasal dose: 200-600mcg per spray 2-3 sprays per nostril typical Follow product guidelines BPC-157 (if attempting nasal): Injection: 250-500mcg Nasal (estimated): 750-1500mcg But: Injection or oral likely better Nasal BPC-157 not well-studied General conversion approach: Start with 2-3x injection dose Assess results after 2-3 uses Increase by 25-50% if weak effects Find minimum effective nasal dose Individual variation significant Cost implications: Using 2-3x more peptide = 2-3x cost Nasal spray more expensive per dose Trade-off: Convenience vs cost Worth it for needle-phobic Not worth it if injections acceptable Use peptide cost calculator to compare routes
If you inject the hormone into the fat layer, the peak of growth hormone in the blood occurs after about 3.5-4 hours, in the muscle, it takes about 2.5 hours
For Tirzepatide stacking specifically, many protocols incorporate TB-500 throughout the weight loss journey for ongoing recovery support
Parent/wild-type (WT), glpQ 1 and glpQ 1 ::glpQ 1 strains growing exponentially in liquid culture were subjected to biphasic extraction [34]
Moreover, essential fatty acids, nucleotides, amines, cholines, organic anions and cations, as well as vitamins, are being transferred into the brain through carrier-mediated transport [83]
KOR and MOR activation block this, either due to direct inhibition of dopamine inputs or inhibition of non-dopaminergic VTA input (Napier and Mitrovic, 1999
